Inceptive Nucleics

Inceptive Nucleics is an AI and biotech company that builds end-to-end foundation models trained on massive, heterogeneous biological data — spanning sequence, function, and structure — to design novel therapeutic molecules including mRNA, siRNA, ASOs, and peptides. Founded in 2021 by AI and biochemistry pioneers, the company operates at the intersection of deep learning and wet-lab science, running iterative in silico and in vitro validation cycles to accelerate drug discovery. Inceptive partners with leading pharmaceutical companies to co-design novel drug candidates, customising foundation models for specific discovery programs. The company is backed by a16z, NVIDIA, and S32, and operates offices in Palo Alto, Berlin, and Zurich.